+7 (495) 505-52-05

" "





2013-06-04 20:44:47

. . . , . 250 . 2 . (34), , 500 . 2 . - ? ....
2013-05-15 20:22:14

10. 20. ? ...
2013-05-05 12:39:07

! 4 , , - , ?...
2013-04-24 10:50:26

! : , . : + + . , , , . 2- . - , . . . 3 ......
2013-04-18 21:36:56

! . 50 . . : - , - , . . . - . - , , . , . . ......

,
:

. ""

HEADING_TITLE_2
?
??
200 Nazaleze LTD
4 N30 McNeil AB
200 Nazaleze LTD
5 N10
50/ 120 Teva Czech Industries s r o
20 N10
0 01% 5 Merck KGaA
20 N30
0 025% 10 Merck KGaA
100 2 N30 /
0 05% 10 Merck KGaA
100 2 N9 /
22 5 10 Merck KGaA
- 100 N20 Teva
0 1+5/ 10
- 100 N30 Teva
0 025/ 10
1% 30 /
0 025/ 10
100 N10
0 125% 10 (15 )
100 N20
0 125/ 150 10
100 N30
50/ 120 -
50/5 60 /
1% 20 / Dr Reddy s Laboratories Ltd
2 5 N30 -
1% 50 / Dr Reddy s Laboratories Ltd
5 N30 -
100 2 N9
100000 30 /
100 N20 Dr Reddy s Laboratories Ltd
250000 N10
600 N20 Dr Reddy s Laboratories Ltd
0 5 N40 -
75 N20
50 N50
N10
50 N50
N20
0 4/ 180 10
N10
0 4/ 200 10 -
79 N3
1% 25 - / IVAX Pharmaceuticals s r o
912 N3
10 N50
N20
30 N30 Lek
50/ 200 Teva Czech Industries s r o
60 N30 Lek
250 N10
4 N5 / - /
3 N60
- 20/ 2 N5 - / /
20% 30 - /
- 40 N100
0 9% 200 N1 - / /
- 40 N24
0 9% 250 N10 - / 1/10
- 40 N6
0 9% 250 - / /
- 40 N64
0 9% 250 - / /
- 40/2 N25 - / Chinoin Pharmaceutical and Chemical Work 1/5
0 9% 500 N10 - /
- 80 N24
0 9% 500 N10 - / 1/10
15+120/ N1 Organon
0 9% 500 - / /
15+120/ N3 Organon
0 9% 10 N10 / /
N10 Dr Reddy s Laboratories Ltd
/ 400
N20 Dr Reddy s Laboratories Ltd
/ 400
N21
- 30
N213
/ 400
- 100 - /
/ 400
- 200 N10
8 Peter Gillhams Natural Vitalyty
- 200 N30
++ N50
- 200 N60
N20 Procter & Gamble
- 100
N8 Procter & Gamble
120 N112
N20 Procter & Gamble
120 N56
N7 Procter & Gamble
0 5% 10 N10 - /
17 39
0 5% 5 N10 - /
N17 39
30 100/ 3 N5 // - /
36 4
1 N30
/ 30 Sweet Tec GmbH
2 N30
36 4
100/ 3 N5 - / / /
36 4
100/ 3 N5 - / / - /
36 4
/ 6930 50
36 4
- / 7005 20
36 4
- 24 4578 25
10% 35
/ 4738 460
0 05% 20 -
() 50
- 25 - /
15
20 / Mekophar Chemical-Pharmaceutical Joint
/ 15
- 5 N56
MH-102 A&D Company Ltd
- 5 N28 Teva
MH-103 A&D Company Ltd
5 N14 -
2 5+0 625 N30 Les Laboratoires Servier Industrie
5 N28 -
5+1 25 N30 Les Laboratoires Servier Industrie
0 1% 5
400 N10 -
75
400 N20 -
3 N3 - / Merck KGaA & Co Werk Spittal
20 N14
N20 Merck KGaA & Co Werk Spittal
20 N28
267 N60
20 N56
15/ 1 N10 - / /
40 N14
5/ 1 N10 - / /
40 N28
2 N10 - / G L Pharma
40 N56
300 N20
N10
/ 100 &
120 N10
/ / 50 &
10 N30 Teva Operations Poland Sp z o o
/ 75 &
10 N60 Teva Operations Poland Sp z o o
/ 50 &
20% 100 - / -
20 N28 AstraZeneca AB
10 N50
40 N28 AstraZeneca AB
400 N48
N10 -
1200 N20 UCB Pharma S A
N20 -
200/ 125 - / NextPharma S a S
N6 -
200/ 5 N12 - / / UCB Pharma S p A
200 N10
800 N30 UCB Pharma S A
200 N20
400 N10 Ranbaxy
100/5 20
10 N14 Pfizer Manufacturing Deutschland
400 N1
10 N30 Pfizer Manufacturing Deutschland
100 2 N10 /
5 N30 Pfizer Manufacturing Deutschland
100 2 N30 /
10
- N16 / /
5 N20
- N24 / /
/ 150
- N24 /
0 3% 5 /
- N14 Bayer Bitterfeld GmbH
N20
- N7 Bayer Bitterfeld GmbH
L 3 N10
- N7 Bayer Bitterfeld GmbH
N20 Anlit Ltd
12 5% 2 N5 - / -
10 N30
3 (3 76) N10 / / -
5 N30
3 (3 76) N10 / / -
500 N30
3 (3 76) N10 / / -
50/ 120 ABC FARMACEUTICI S p A
3 (3 76) N30 / / -
50/ 240 ABC FARMACEUTICI S p A
50
500 N30
100
/ N60
100
N60
N50 / Biologische Heilmittel Heel GmbH
400 N10
250 Nesti Dante
400 N20
4% 125 -
200 N10
300 N60
200 N20
250 N60
200 N8 / 6
N10
60 N10 /
2% 120
100/5 100 / ()
15/16 N7 McNeil AB
100/5 150 / ()
1/ 13 2 N2 / []
100/5 150 / ()
1/ 150 13 2 / McNeil AB
100/5 200 / ()
25/16 N7 McNeil AB
100/5 200 / ()
2 N30 McNeil AB
N12 Reckitt Benckiser
2 N30 McNeil AB
N6 Reckitt Benckiser
2 N30 McNeil AB
400 N12
4 N30 McNeil AB
200 N16 Banner Pharmacaps Europe B V